Abstract：
The UK has fallen from fourth to 10th place in the global ranking for clinical trial activities in the past 6 years. Due to the limited capacity of the clinical trial pharmacy workforce and delays in providing pharmacy approvals, pharmacy has been identified as one of the constraining services that delays the set-up and delivery of clinical trials. To tackle this problem, we developed a single pharmacy review process for multicentre trials across Greater Manchester (GM) and tested its feasibility and implementation in our region. A survey completed by each GM Trust suggests that this harmonised pharmacy review process for multicentre studies would expedite trial set-up time at each pharmacy site and standardise the pharmacy review process in GM. We therefore believe that this harmonised review process could potentially reduce pharmacy set-up time and reposition the UK in the global market for clinical trials.
摘要：
在过去的6年中，英国在全球临床试验活动排名中从第四位下降到第十位。由于临床试验药房劳动力的能力有限以及提供药房批准的延迟，药房已被确定为延迟建立和交付临床试验的限制服务之一。为了解决这个问题，我们为大曼彻斯特(GM)的多中心试验开发了单药房审查流程,并测试了其在本地区的可行性和实施情况.每个GMTrust完成的一项调查表明，这种多中心研究的统一药房审查程序将加快每个药房站点的试验设置时间，并使GM的药房审查程序标准化。因此，我们认为，这种协调的审查过程可能会减少药房设置时间，并在全球市场上重新定位英国的临床试验。
